Trevor F. Cox

Time-dependent ROC curve analysis in medical research: current methods and applications

Adina Najwa Kamarudin, Trevor F. Cox, Ruwanthi Kolamunnage‐Dona · BMC Medical Research Methodology · 2017 · 866 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +8

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma

John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox et al. · JAMA · 2012 · 592 citations

Medicine, Oncology, Surgery +17

Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

Juan W. Valle, Daniel H. Palmer, Richard Jackson et al. · Journal of Clinical Oncology · 2014 · 455 citations · Full text

Medicine, Oncology, Surgery +16

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Gary Middleton, Paul Silcocks, Trevor F. Cox et al. · The Lancet Oncology · 2014 · 374 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers

Philip J. Johnson, Sarah Pirrie, Trevor F. Cox et al. · Cancer Epidemiology Biomarkers & Prevention · 2013 · 335 citations

Medicine, Biostatistics, Oncology +17